期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

老年人血栓调节蛋白与冠状动脉病变的相关性研究 被引量：4

原文传递
导出
摘要 目的探讨老年冠状动脉粥样硬化性心脏病(冠心病)患者血栓调节蛋白(TM)与冠状动脉粥样硬化程度之间的关系。方法80例住院冠心病患者按螺旋CT冠状动脉钙化积分值分成4组:低度危险组42例,中度危险组8例,重度危险组24例,极度危险组6例。比较4组血浆TM值。结果4组间的血浆TM随着钙化总积分的增加而增加,差异均有统计学意义(均P<0.01)。相关分析结果表明,血浆TM值和冠状动脉钙化总积分呈正相关(r=0.957,P<0.01)。结论血浆TM水平是反映老年冠心痛患者内皮损伤的良好标志。也是评价冠状动脉粥样硬化狭窄程度的指标。
作者 潘志红 张江蓉 袁惠敏 刘芳 李东霞 潘永瑜
机构地区 上海交通大学医学院附属新华医院老年科
出处 《中国综合临床》 北大核心 2007年第12期1059-1060,共2页 Clinical Medicine of China
关键词 冠心病 血栓调节蛋白 内皮细胞
分类号 R543 [医药卫生—心血管疾病]
  • 相关文献

参考文献6

  • 1Blann AD, Tabemer DA, Are liable marker of endothelial cell dysfunction:does it exist[J]. Br J Haematol,1995,90(2) :224-229.
  • 2Salemaa V, Wu KK. Soluble thrombomodulin as predictor of incident coronary heart disease[J]. Lancet,1999,353(9166) :1729-1734.
  • 3Conway EM, Vande W. The lectin-like domain of thrombomodulin confers by suppressing adhesin activated protein kinase pathways [ J]. The Journal of Experimental Medicine, 2002, 196 ( 5 ) : 565- 577.
  • 4Li YH,Chen JH,Wu HL,et al. G-33A mutation in the promoter rogion of thrombomodulin gene and its association with coronary artery disease and plasma soluble thrombomodulin levels[ J]. Am J Cardiol,2000,85(1 ) :8-12.
  • 5章宏祥,段宝祥.血浆血栓调节蛋白的含量与冠心病[J].医学综述,2005,11(3):218-220. 被引量：1
  • 6Blann AD, Tabemer DA. Are liable marker of endothelial cell dysfunction:does it exlst[J]. Br J Haematol,1995,90(2) :224-228.

二级参考文献20

  • 1Esmon CT, Owen WG. Identification of an endothelial cell cofactor for the Thrombin-Catalyzed activation of Protein C[J] .Proc Nail Acad Sci USA, 1981.78(4) :2249-2252.
  • 2Nawa K,Sakano K,Fujiwara H,et al . Presence and function of chondroitin-4-sulfate on recombinant human soluble thrombomodulin [J].Biochem Biophy Res Commun, 1990,171(2) :729-737.
  • 3Kokame K, Zheng X, Sadie J. Actiratin of thrombin-activatable fibrinolysis inhibitor requires epidermal growth factor-like domain 3 of thrombomodulin and is inhibited competitively by protein C[J] .J Biol Chem,1998.273(20) : 12135-12139.
  • 4Suzuki K,Hayashi T,Nishioka J, et al.A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and protein C activation[J] .J Biol Chem, 1989,264(9) :4872-4876.
  • 5Petersen TE. The amino-terminal domain of thrombomodulin and pancreatic stone protein are homologous with lectins[J]. FEBS Lett, 1988,231(1) :51-55.
  • 6Drickamer K. Two distinct classes of carbohydrate-recognition domains in animal leetins[J] .J Biol Chem, 1988,263(20):9557-9560.
  • 7Le Flem L,Picard V, Emmerich J, et al. Mutations in promoter region of thrombomodulin and venous thromboembolic disease [J]. Arterioscler Thromb Vasc Biol, 1999,19(4) : 1098-1104.
  • 8Conway EM, Van de Wouwer M, Pollefeyt S, et al. The lectin-like domain of thromhomodulin confers by suppressing adhesin activated protein kinase pathways[J] .J Exp Med,2002,196(5) :565-577.
  • 9Li YH, Chen JH, Wu HL,et al. G-33A mutation in the promoter region of thrombomodulin gene and its association with coronary artery disease and phsma soluble thrombomodulin leveh[J]. Am J Cardiol, 2000,85(1) :8-12.
  • 10Ireland HA,Kunz G,Kyriakouis K,et al.Thrombomodulin gene mutaotions associated with myocardial infarction[J]. Circulation, 1997, 96(1):15-18.

同被引文献42

  • 1沈培辰,张代富,王娟,马兰.急性心肌梗死患者血浆TAT变化的价值[J].实用全科医学,2005,3(6):477-478. 被引量：5
  • 2陈欣,张广梅,江雁,郭素箴,党群.急性冠脉综合征患者血栓调节蛋白Ala455Val(C1 418T)多态性的研究[J].天津医药,2006,34(12):841-843. 被引量：6
  • 3Krnmholz HM. Platelet receptor inhibition for ischemic syndromes [J]. Journal Watch Cardiology,1997,338:1498-1505.
  • 4Huggins GS, Pastemak PC, Alpert NM, et al. Effects short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse [J]. Circulation,1998,98(13):1291-1296.
  • 5Tataru MC, Heinrich J, JunKer R, et al. C-reactive protein and the aeverity of atherosclerosis in myocardial infarction patients with stable angina pectoris [J]. Eor Heart J,2000,21(12):1000.
  • 6Takahashi H, Ito S, Hanano M, et al. Circulating thrombomodulin as a novel endothelial cell marker: comparison of its behavior with yon Willebrand factor and tissue-type plasminogen activator. Am J Hematol, 1992,41 ( 1 ) :32-39.
  • 7Cuchacovich R. Immunopathogenesis of vasculitis. Curr Rheumatol Rep ,2002,4 ( 1 ) :9-17.
  • 8Merci6 P, Seigneur M, Constans J, et al. Assay of plasma thrombomodulin in systemic diseases. Rev Med Interne, 1997,18 (2) :126- 131.
  • 9Besbas N, Erbay A, Saatgi U, et al. Thrombomodulin, tissue plasminogen activator and plasminogen activator inhibitor-1 in Henoch- Sch~nlein purpura. Clin Exp Rheumatol, 1998,16 ( 1 ) :95-98.
  • 10余洪立,黄锦雄,韦秀英,覃绍鹏.血浆血栓调节蛋白、血小板γ-颗粒膜蛋白、Von willebrand因子变化与早期糖尿病肾病的关系[J].中国综合临床,2008,24(1):14-16. 被引量：4

引证文献4

二级引证文献3

中国综合临床
2007年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部